What is Enveric Biosciences Inc?
, a biotechnology company, focuses on the development of small molecule neuroplastogenic therapeutics that address unmet needs in psychiatric and neurological disorders in the United States.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a biotechnology company, focuses on the development of small molecule neuroplastogenic therapeutics that address unmet needs in psychiatric and neurological disorders in the United States. Its lead drug candidate is EB-003, a novel derivative of DMT in preclinical development for mental health indications. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 6.04M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.